Cargando…
Effect of methotrexate/vitamin B(12) on DNA methylation as a potential factor in leukemia treatment-related neurotoxicity
Methotrexate (MTX) is administered to treat childhood acute lymphoblastic leukemia (ALL). It acts by inhibiting dihydrofolate reductase which reduces methyltetrahydrofolate, a key component in one carbon metabolism, thus reducing cell proliferation. Further perturbations to one carbon metabolism, su...
Autores principales: | Forster, Victoria J, McDonnell, Alex, Theobald, Rachel, McKay, Jill A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638018/ https://www.ncbi.nlm.nih.gov/pubmed/28809129 http://dx.doi.org/10.2217/epi-2016-0165 |
Ejemplares similares
-
Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patients
por: Forster, Victoria J., et al.
Publicado: (2016) -
Genetic and Non-Genetic Influences during Pregnancy on Infant Global and Site Specific DNA Methylation: Role for Folate Gene Variants and Vitamin B(12)
por: McKay, Jill A., et al.
Publicado: (2012) -
Bi-directional effects of vitamin B(12) and methotrexate on Daphnia magna fitness and genomic methylation
por: Kusari, Fitore, et al.
Publicado: (2017) -
P389: METHOTREXATE NEUROTOXICITY IN ADULT ALL
por: Levavi, Hannah, et al.
Publicado: (2023) -
Methotrexate Neurotoxicity Is Related to Epigenetic Modification of the Myelination Process
por: Chen, Yu-Chieh, et al.
Publicado: (2021)